Image 1 of 1
Image 1 of 1
Image 1 of 1
Image 1 of 1
Olaparix is a branded generic version of the prescription oncology medication olaparib, manufactured by Kenneth Pharmaceuticals in Bangladesh. It belongs to a class of medications called PARP (poly-ADP ribose polymerase) inhibitors and is primarily utilized as a targeted therapy to treat specific adult cancers that frequently exhibit BRCA gene mutations.
Olaparix is a branded generic version of the prescription oncology medication olaparib, manufactured by Kenneth Pharmaceuticals in Bangladesh. It belongs to a class of medications called PARP (poly-ADP ribose polymerase) inhibitors and is primarily utilized as a targeted therapy to treat specific adult cancers that frequently exhibit BRCA gene mutations.